Abstract

BackgroundSolid pseudopapillary neoplasms of the pancreas (SPNs) in male patients are more frequently reported. The aim of the study was to evaluate the sex features of SPN and the risk factors that predict tumor recurrence.MethodsFrom 2013 to 2019, patients who were pathologically confirmed to have SPNs were retrospectively reviewed. The baseline study parameters were compared between males and females. A logistic regression model was established to identify the independent risk factors for tumor recurrence.ResultsIn total, 221 patients were included in this study. Of them, 53 patients (24.0%) were males. Male patients were older than female patients (39.1 vs 31.6 years, P=0.001), and the tumor size in male patients was smaller than that in female patients (50.38 vs 39.65 mm, P=0.038). The preoperative imaging diagnostic accuracy was significantly higher in females than in males (70.5% vs 54%, P=0.02). SPNs in male patients tended to be misdiagnosed with other malignant tumors (37.7% vs 10.7%, P<0.0001), with a more solid component observed in images (66.8% vs 24.7%, P<0.0001). For immunohistochemical staining, the expression of beta catenin was significantly lower in male patients (P=0.002), and the expression of vimentin was the opposite (P=0.01). The overall survival rate and disease-free survival were not different. Based on multivariate analysis, older age [hazard ratio (HR)= 1.094, 95% confidence interval (CI): 1.005-1.190] and KI 67 index grade III (HR=12.029, 95% CI: 2.399-60.311) were independent risk factors for tumor recurrence.ConclusionThe clinical and imaging features of SPN in males were not in full accord with those in females; however, the differences did not influence prognosis.

Highlights

  • SPNs in male patients tended to be misdiagnosed with other malignant tumors (37.7% vs 10.7%, P

  • Older age [hazard ratio (HR)= 1.094, 95% confidence interval (CI): 1.005-1.190] and KI 67 index grade III (HR=12.029, 95% CI: 2.399-60.311) were independent risk factors for tumor recurrence

  • SPNs in male patients tended to be misdiagnosed with malignant tumors more often than SPNs in female patients (37.7% vs 10.7%, c2 = 20.662, P

Read more

Summary

Introduction

These tumors account for approximately 0.9%-2.7% of all exocrine pancreatic neoplasms [1, 2] and approximately 3%-5% of pancreatic cystic neoplasms [3, 4]. SPNs occur predominantly in young women, with an overall female-male ratio of 9.8:1 reported in previous studies [1, 2]. The phenomenon that more male SPN patients have been identified has attracted increasing attention from clinicians and researchers [10]. Solid pseudopapillary neoplasms of the pancreas (SPNs) in male patients are more frequently reported. The aim of the study was to evaluate the sex features of SPN and the risk factors that predict tumor recurrence

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call